Concentrix (NASDAQ:CNXC) Issues Earnings Results, Misses Expectations By $0.01 EPS

Concentrix (NASDAQ:CNXC) announced its quarterly earnings results on Monday. The company reported $2.63 EPS for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01), FiscalAI reports. Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.The business had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.47 billion. Concentrix updated its FY 2026 guidance to 10.830-11.180 EPS and its Q3 2026 guidance to 2.650-2.770 EPS.

Concentrix Stock Performance

Shares of CNXC stock traded up $0.23 on Monday, reaching $25.23. The stock had a trading volume of 3,761,870 shares, compared to its average volume of 1,622,832. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.18 and a current ratio of 1.18. Concentrix has a 1 year low of $22.05 and a 1 year high of $62.14. The stock has a market cap of $1.54 billion, a P/E ratio of -1.17, a price-to-earnings-growth ratio of 0.31 and a beta of 0.43. The company has a 50 day simple moving average of $25.93 and a 200 day simple moving average of $32.17.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Barrington Research reiterated an “outperform” rating and issued a $38.00 price objective on shares of Concentrix in a report on Monday, June 22nd. Canaccord Genuity Group cut their target price on Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a research note on Wednesday, March 25th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Concentrix in a report on Monday, April 27th. Robert W. Baird reduced their price objective on Concentrix from $52.00 to $40.00 and set an “outperform” rating for the company in a report on Wednesday, March 25th. Finally, Wall Street Zen lowered Concentrix from a “buy” rating to a “hold” rating in a research report on Saturday, March 28th. Three research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $44.33.

Insiders Place Their Bets

In other news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the company’s stock in a transaction dated Wednesday, April 29th. The shares were sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the completion of the sale, the insider owned 2,773,667 shares of the company’s stock, valued at $61,714,090.75. This represents a 68.39% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Andre S. Valentine acquired 2,500 shares of the company’s stock in a transaction that occurred on Thursday, April 9th. The stock was acquired at an average cost of $27.95 per share, for a total transaction of $69,875.00. Following the acquisition, the chief financial officer owned 89,066 shares of the company’s stock, valued at $2,489,394.70. The trade was a 2.89% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.90% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Concentrix

Hedge funds have recently modified their holdings of the business. Geneos Wealth Management Inc. raised its holdings in Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after purchasing an additional 522 shares during the period. Larson Financial Group LLC increased its stake in shares of Concentrix by 224.9% in the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock worth $32,000 after purchasing an additional 479 shares in the last quarter. Global Retirement Partners LLC boosted its holdings in Concentrix by 1,032.5% in the 4th quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock worth $36,000 after buying an additional 795 shares during the period. Johnson Financial Group Inc. bought a new stake in Concentrix during the third quarter valued at about $69,000. Finally, Osaic Holdings Inc. boosted its stake in shares of Concentrix by 13.4% in the second quarter. Osaic Holdings Inc. now owns 2,222 shares of the company’s stock worth $118,000 after acquiring an additional 263 shares during the period. Institutional investors own 90.34% of the company’s stock.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.